Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.

BACKGROUND: Acute ischaemic stroke is common in older people. There is one licensed acute treatment, intravenous recombinant tissue plasminogen activator, but little information is available on its safety in over 80 year olds. DESIGN: Review of prospectively collected data on 62 consecutive patient...

Full description

Bibliographic Details
Main Authors:	Simon, J, Sandler, D, Pexman, J, Hill, MD, Buchan, A
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.
by: Balami, J, et al.
Published: (2013)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
by: Soichiro Shibata, et al.
Published: (2022-11-01)

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: A review of rtPA neurotoxicity
by: Harston, G, et al.
Published: (2010)

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.
by: Harston, G, et al.
Published: (2010)

Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block
by: AR, Siti Noor Atikah, et al.
Published: (2022)

Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block
by: Siti Noor Atikah AR,, et al.
Published: (2022)

Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.
by: Ryu Matsuo, et al.
Published: (2014-01-01)

Destruction of Recombinant Tissue Plasminogen Activator (rtPA) -Loaded Echogenic Liposomes under Dual Frequency Sonication
by: Mosayyeb Mobasheri, et al.
Published: (2018-05-01)

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
by: Tanne, D, et al.
Published: (2002)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
by: Chapman SN, et al.
Published: (2014-02-01)

The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage.
by: Thiex, R, et al.
Published: (2003)

Intravenous thrombolysis for acute ischaemic stroke in young adult patients.
by: Poppe, A, et al.
Published: (2009)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial
by: Pratima Chowdary, et al.
Published: (2023-09-01)

Effects of intravenous rtPA in patients with minor stroke
by: Zhihao Lei, et al.
Published: (2024-12-01)

Effect of P19 gene expression on transcription rate and production of recombinant human tissue plasminogen (rtPA) in tobacco (nicotiana benthamiana)
by: Yousef Sharafi, et al.
Published: (2020-08-01)

Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients?
by: Dzialowski, I, et al.
Published: (2012)

Intravenous thrombolysis with recombinant tissue plasminogen activator in vascular warning syndromes
by: A. González Hernández, et al.
Published: (2014-07-01)

Prediction of functional outcome in supratentorial intracerebral hemorrhage patients treated with stereotactic computed tomographic-guided aspiration and recombinant tissue plasminogen activator (rt-PA)
by: Lan H. Dang, et al.
Published: (2024-09-01)

How well does ASPECTS predict the outcome of acute stroke treated with IV tPA?
by: Weir, N, et al.
Published: (2006)

Reply: Intravenous thrombolysis for ischaemic strokes: a call for reappraisal.
by: Balami, J, et al.
Published: (2014)

Safety and outcome of intravenous thrombolysis with rtPA in patients with atrial fibrillation
by: Elena Terecoasa, et al.
Published: (2012-09-01)

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study.
by: Sylaja, P, et al.
Published: (2006)

Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
by: Demaerschalk, B, et al.
Published: (2003)

Intra-arterial thrombolysis for retinal artery occlusion: the Calgary experience.
by: Pettersen, J, et al.
Published: (2005)

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
by: Sandercock, P, et al.
Published: (2012)

Intravenous Tissue Plasminogen Activator Can Be Safely Given without Complete Blood Count Results Back.
by: Yi Dong, et al.
Published: (2015-01-01)

Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction
by: Fan Sun, et al.
Published: (2020-05-01)

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.
by: Hill, MD, et al.
Published: (2000)

Predictors of intracerebral hemorrhage in acute stroke patients receiving intravenous recombinant tissue plasminogen activator
by: Vijay Chenna, et al.
Published: (2018-01-01)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
by: Sadeghi-Hokmabadi E, et al.
Published: (2016-10-01)

Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
by: Nabil Mohamed, et al.
Published: (2020-01-01)

The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies.
by: Barber, P, et al.
Published: (2004)

The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies
by: Afshin Afshari R. Elizbeth Holme
Published: (2004-09-01)

Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke?
by: Rothwell, P
Published: (2009)

Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging.
by: Barber, P, et al.
Published: (2005)

Is glucose a predictor of hemorrhage after rtPA therapy in acute stroke?
by: Demchuk, A, et al.
Published: (1998)

Retracted: Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Clinical study of low ⁃ dose rt ⁃ PA combined with transcranial Doppler ultrasonography assisted intravenous thrombolysis
by: YUAN Chang⁃hong, et al.
Published: (2021-04-01)

Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016-06-01)

Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial
by: Pavlina Richtrova, et al.
Published: (2021-01-01)